Global stocks, euro fall as Macron win shifts focus to economy

Global stocks, euro fall as Macron win shifts focus to economy

His fledgling political movement must now scramble together a majority in the parliamentary elections - which will not be an easy task. Mr Alex Capri, visiting senior fellow at National University of Singapore's Business School, said Mr Marcon's election is not a guarantee of stability or cohesion in France or in the European Union, as fundamental issues fuelling populism remains.

I'm not picking a fight with the banks: Australia Treasurer tells CNBC

The Treasurer has jettisoned decades of conservative fiscal orthodoxy around deficits and, particularly, debt. The government takes on the banks at their peril. Schools to receive an extra A$18.6 billion over 10 years, but university students to face higher fees ranging from A$2,000 to A$3,600 for a four-year course.

Snapchat parent company reports £1.7bn loss in first earnings report

Investors were expecting the company to report 16 cents loss per share on revenue, but the company reported $2.31 per share. Shares in Snap plunged 24 percent in after-hours trade to US$17.45 following the results. All the copying appears to be paying off for Facebook . Snapchat had 166 million active daily users at the end of the quarter, up 36% from last year's first quarter, but well below the 400 million that Instagram has.

Secure Income REIT PLC (SIR) Declares Dividend of GBX 3.28

AZN's profit will be $1.12 billion for 17.64 P/E if the $0.44 EPS becomes a reality. The company was maintained on Wednesday, November 30 by BNP Paribas. Credit Suisse Ag reported 53,067 shares. STV Group Plc. (LON:STVG) has declined 0.07% since October 10, 2016 and is downtrending. Apg Asset Mgmt Nv holds 0.05% of its portfolio in Compass Group plc (LON:CPG) for 1.99M shares.

Applied Materials, Inc. (NASDAQ:AMAT) Jumped 1.55% in Pre-Market

It is negative, as 64 investors sold AMAT shares while 272 reduced holdings. Applied Materials, Inc. has far performed well this year, with the share price up 33.23% since January. Many investors may be looking to track stock price momentum by looking at different historical information. This represents an increase of 346% compared to the typical volume of 583 call options.

Is Ionis Pharmaceuticals, Inc. (IONS) a good buy?

Is Ionis Pharmaceuticals, Inc. (IONS) a good buy?

Currently, the stock has a 1 Year Price Target of $47. During the same quarter past year, the company posted ($0.52) EPS. Several other research analysts have also issued reports on the stock. Corporate insiders own 1.86% of the company's stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website .